Home/Filings/4/0001415889-24-006267
4//SEC Filing

Borgman Anne Elizabeth 4

Accession 0001415889-24-006267

CIK 0001382101other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 4:15 PM ET

Size

9.0 KB

Accession

0001415889-24-006267

Insider Transaction Report

Form 4
Period: 2024-02-29
Borgman Anne Elizabeth
CHIEF MEDICAL OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-29+37,50037,500 total
  • Tax Payment

    Common Stock

    2024-02-29$4.91/sh13,126$64,44924,374 total
  • Exercise/Conversion

    Restricted Stock Unit (RSU)

    2024-02-2937,500112,500 total
    Exp: 2027-02-28Common Stock (37,500 underlying)
Footnotes (3)
  • [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
  • [F2]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
  • [F3]The RSU award vests as to 1/4th of the total award annually on the last calendar day of February, beginning on February 29, 2024, subject to continued service through each vesting date.

Issuer

SUTRO BIOPHARMA, INC.

CIK 0001382101

Entity typeother

Related Parties

1
  • filerCIK 0001886388

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:15 PM ET
Size
9.0 KB